Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis

Journal of Immunology

Volumn 171, Issue 1, 2003, Pages 61-68

  Jaleco, Sara ^a   Swainson, Louise ^a   Dardalhon, Valérie ^a   Burjanadze, Maryam ^a   Kinet, Sandrina ^a   Taylor, Naomi ^a,b  

^a CNRS   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CD69 ANTIGEN; CYTOKINE; FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 7; PEPTIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 0038545516     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.1.61     Document Type: Article

References (64)

1. Boursalian, T. E., and K. Bottomly. 1999. Survival of naive CD4 T cells: roles of restricting versus selecting MHC class II and cytokine milieu. J. Immunol. 162:3795.
2. Murali-Krishna, K., L. L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286:1377.
3. + T cells. Nat. Immunol. 1:107.
4. Tanchot, C., F. A. Lemonnier, B. Peramau, A. A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057.
5. + T cells in vivo by IL-15. Immunity 8:591.
6. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrançois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426.
7. Alpdogan, O., C. Schmaltz, S. J. Muriglan, B. J. Kappel, M. A. Perales, J. A. Rotolo, J. A. Halm, B. E. Rich, and M. R. van den Brink. 2001. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98:2256.
8. Fry, T. J., B. L. Christensen, K. L. Komschlies, R. E. Gress, and C. L. Mackall. 2001. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 97:1525.
9. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al. 2002. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected non-human primates. Blood 31:31.
10. Steffens, C. M., E. Z. Managlia, A. Landay, and L. Al-Harthi. 2002. Interleukin7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 99:3310.
11. Geiselhart, L. A., C. A. Humphries, T. A. Gregorio, S. Mou, J. Subleski, and K. L. Komschlies. 2001. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J. Immunol. 166:3019.
12. Hassan, J., and D. J. Reen. 2001. Human recent thymic emigrants-identification, expansion, and survival characteristics. J. Immunol. 167:1970.
13. + T cells. Proc. Natl. Acad. Sci. USA 98:9277.
14. Berzins, S. P., R. L. Boyd, and J. F. Miller. 1998. The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J. Exp. Med. 187:1839.
15. Peter, M. E., C. Scaffidi, J. P. Medema, F. Kischkel, and P. H. Krammer. 1999. The death receptors. Results Probl. Cell Differ. 23:25.
16. Owen-Schaub, L. B., S. Yonehara, W. L. Crump 3rd, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
17. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
18. Robertson, M. J., T. J. Manley, G. Pichert, C. Cameron, K. J. Cochran, H. Levine, and J. Ritz. 1995. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma 17:51.
19. + T cell responses to Fas engagement. Proc. Natl. Acad. Sci. USA 96:8104,
20. Inaba, M., K. Kurasawa, M. Mamura, K. Kumano, Y. Saito, and I. Iwamoto. 1999. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J. Immunol. 163:1315.
21. + T cells. J. Immunol. 163:1817.
22. + T cells enables preservation of a naive repertoire. J. Immunol. 161:5909.
23. + T-cell pool. Immunology 98:400.
24. + T cells. Eur. J. Immunol. 28:3057.
25. + memory T cells by opposing cytokines. Science 288:675.
26. Li, X. C., G. Demirci, S. Ferrari-Lacraz, C. Groves, A. Coyle, T. R. Malek, and T. B. Strom. 2001. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat. Med. 7:114.
27. Zamorano, J., H. Y. Wang, R. Wang, Y. Shi, G. D. Longmore, and A. D. Keegan. 1998. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J. Immunol. 160:3502.
28. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11:281.
29. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169.
30. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
31. Suda, T., H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186:2045.
32. Aggarwal, S., A. Gupta, S. Nagata, and S. Gupta. 1997. Programmed cell death (apoptosis) in cord blood lymphocytes. J. Clin. Immunol. 17:63.
33. Renno, T., M. Hahne, J. Tschopp, and H. R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183:431.
34. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, K. M. el, D. H. Sherr, B. Z. Stanger, and R. A. Marshak. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
35. Parlato, S., A.M. Giammarioli, M. Logozzi, F. Lozupone, P. Matarrese, F. Luciani, M. Falchi, W. Malomi, and S. Fais. 2000. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19:5123.
36. Lee, Y., and E. Shacter. 2001. Fas aggregation does not correlate with Fas-mediated apoptosis. J. Immunol. 167:82.
37. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221.
38. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293.
39. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98:8732.
40. Mackall, C. L., T. J. Fry, C. Bare, P. Morgan, A. Galbraith, and R. E. Gress. 2001. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97:1491.
41. Bolotin, E., G. Annett, R. Parkman, and K. Weinberg. 1999. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant. 23:783.
42. Fry, T. J., E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman et al. 2001. A potential role for interleukin-7 in T-cell homeostasis. Blood 97:2983.
43. Napolitano, L. A., R. M. Grant, S. G. Deeks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson, and J. M. McCune. 2001. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7:73.
44. Mastroianni, C. M., G. Forcina, G. d'Ettorre, M. Lichtner, F. Mengoni, C. D'Agostino, and V. Vullo. 2001. Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy-treated HIV-infected patients. HIV Clin. Trials 2:108.
45. Harris, N. L., V. Watt, F. Ronchese, and G. Le Gros. 2002. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195:317.
46. Sopper, S., D. Nierwetberg, A. Halbach, U. Sauer, C. Scheller, C. Stahl-Hennig, K. Maetz-Rensing, F. Schaefer, T. Schneider, V. Ter Meulen, and J. G. Mueller. 2002. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood 10:10.
47. + T cells. J. Immunol. Methods 271:99.
48. Nath, M. D., F. W. Ruscetti, C. Petrow-Sadowski, and K. S. Jones. 2003. Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood 101:3085.
49. Akbar, A. N., M. Salmon, J. Savill, and G. Janossy. 1993. A possible role for bcl-2 in regulating T-cell memory - a "balancing act" between cell death and survival. Immunol. Today 14:526.
50. + T cells. Eur. J. Immunol. 19:771.
51. + T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol. Today 19:60.
52. Michie, C.A., A. McLean, C. Alcock, and P. C. Beverley. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360:264.
53. Tough, D. F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127.
54. + T cells can be sensitized with IL-7. Scand. J. Immunol. 54:501.
55. Robinson, K. L., J. Ayello, R. Hughes, C. van de Ven, L. Issitt, J. Kurtzberg, and M. S. Cairo. 2002. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with 1L IL-12, anti-CD3, and IL-7: potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Exp. Hematol. 30:245.
56. + T cells in lymphopenic hosts. Immunity 11:183.
57. Ernst, B., D. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11:173.
58. + T cells. J. Exp. Med. 194:1711.
59. Jameson, S. C. 2002. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2:547.
60. Prlic, M., L. Lefrancois, and S. C. Jameson. 2002. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195:F49.
61. Verhoeyen, E., V. Dardalhon, O. Ducrey-Rundquist, D. Trono, N. Taylor, and F. L. Cosset. 2003. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101:2167.
62. Gadina, M., C. Sudarshan, R. Visconti, Y. J. Zhou, H. Gu, B. G. Neel, and J. J. O'Shea. 2000. The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common γ chain-using cytokines. J. Biol. Chem. 275:26959.
63. Fry, T. J., and C. L. Mackall. 2002. Interleukin-7: from bench to clinic. Blood 99:3892.
64. Paredes, R., J. C. Lopez Benaldo de Quiros, E. Femandez-Cruz, B. Clotet, and H. C. Lane. 2002. The potential role of interleukin-2 in patients with HIV infection. AIDS Rev. 4:36.